According to news on the website of the National Development and Reform Commission on the 10th, the National Development and Reform Commission issued a notice on printing and distributing the "14th Five-Year Plan for Bioeconomic Development". Many of the notices involved automated cell preparation and cell therapy. This article intercepts the relevant content for everyone, for reference only.

 

　　(9) Promote the development of the medical and health industry.

　　Improve clinical medical level. Develop advanced technologies such as microfluidic chips and cell preparation automation , promote the development of biological drugs such as antibody drugs, recombinant proteins, peptides, cell and gene therapy products , and encourage the advancement of major and rare diseases such as chronic diseases, tumors, and neurodegenerative diseases. Drug Discovery. Expand the clinical application of advanced treatment technologies such as intelligent surgical robots and digital therapy particle radiotherapy. Formulate and improve technical specifications for stem cell therapy, cellular immunotherapy, and new medical technologies for clinical applications, and conduct clinical evaluations scientifically.

 

　　Formulate and improve technical specifications for stem cell therapy, cellular immunotherapy, and new medical technologies for clinical applications, and conduct clinical evaluations scientifically.

 

　　(25) Promote policies to be first and foremost.

Make good use of the sub-centers for technical review and inspection of drugs and medical devices　　in the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area , and encourage pilot reforms in areas such as cell therapy, traditional Chinese medicine and traditional Chinese medical device registration and supervision relying on the Pilot Free Trade Zone and Hainan Free Trade Port. Combined with the construction of a highland for bio-economy innovation and development and a new round of comprehensive innovation and reform experiments, select cities with a good industrial foundation, active market players, and strong radiation and drive, and build a number of bio-economy pilot areas to pilot technological innovation, access and supervision, and market Reform measures in key areas of the bio-economy, such as application, financial innovation, price, and foreign cooperation, fully gather high-level innovation resources at home and abroad, and encourage the development of new technologies, new industries, new forms of business, and new models .

 

　　(5) Accelerate the improvement of biotechnology innovation capabilities.

　　Develop new technologies such as gene diagnosis and treatment, stem cell therapy, and immune cell therapy , strengthen the synergy between industry, academia, and research, accelerate the transformation and clinical application of related technologies, and promote the formation of new models of regenerative medicine and precision medicine.

　　Bioeconomy Innovation Capability Improvement Project

Build quality and safety evaluation technology platforms for 　　antibody drugs, fusion protein drugs, biosimilars, stem cells and cellular immunotherapy products, gene therapy products , exosome therapy products , and traditional Chinese medicines.

 

　　Screenshots of related files